What's new

Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised

Jun 17, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Aspaveli, pegcetacopla...

Next Article

Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, ...

Related Posts

HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 October 2025, 10:00 (CEST) to 9 October 2025, 16:10 (CEST)

HMA/EMA multi-stakeholder workshop on reporting and qua...

May 23, 2025  0

EMEA-003176-PIP02-22

EMEA-003176-PIP02-22

May 13, 2025  0

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva IBm+ND+EDS, infectious bronchitis,Newcastle disease,egg drop syndrome virus vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report ...

Jun 2, 2025  0